<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1a221b63a">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>Senate</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>BILLS</collectionCode>
         <searchTitle>To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.;Mainstreaming Addiction Treatment Act of 2019;S. 2074 (IS)
    </searchTitle>
         <category>Bills and Statutes</category>
         <waisDatabaseName>116_cong_bills</waisDatabaseName>
         <branch>legislative</branch>
         <dateIngested>2019-07-16</dateIngested>
    </extension>
    <titleInfo>
         <title>To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>Mainstreaming Addiction Treatment Act of 2019</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>S. 2074 (IS)
    </title>
    </titleInfo>
    <originInfo>
         <publisher>U.S. Government Publishing Office</publisher>
         <dateIssued encoding="w3cdtf">2019-07-10</dateIssued>
         <issuance>monographic</issuance>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>8 p.</extent>
    </physicalDescription>
    <classification authority="sudocs">Y 1.6:</classification>
    <classification authority="sudocs">Y 1.4/1:</classification>
    <identifier type="local">P0b002ee1a221b63a</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/BILLS-116s2074is</identifier>
    <identifier type="preferred citation">S. 2074</identifier>
    <identifier type="stock number">021-610-00252-9</identifier>
    <identifier type="Parent ILS system id">000501532</identifier>
    <identifier type="Child ILS system id">000325576</identifier>
    <identifier type="Parent ILS title">Congressional bills</identifier>
    <identifier type="Child ILS title">Senate bills</identifier>
    <identifier type="former package identifier">f:s2074_is.txt</identifier>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/BILLS-116s2074is</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-116s2074is/html/BILLS-116s2074is.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-116s2074is/pdf/BILLS-116s2074is.pdf</url>
         <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-116s2074is/xml/BILLS-116s2074is.xml</url>
    </location>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2019-07-16</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2023-01-02</recordChangeDate>
         <recordIdentifier source="DGPO">BILLS-116s2074is</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <name type="personal">
         <namePart>Margaret Wood Hassan</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm authority="marcrelator" type="text">sponsor</roleTerm>
              <roleTerm authority="marcrelator" type="code">spn</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Lisa Murkowski</namePart>
         <affiliation>United States Senate</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>Senate</namePart>
         <namePart>Committee on Health, Education, Labor, and Pensions</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 21 Section 802</partNumber>
              <partNumber>Title 21 Section 822</partNumber>
              <partNumber>Title 21 Section 823(g)</partNumber>
              <partNumber>Title 21 Section 824</partNumber>
              <partNumber>Title 21 Section 829a(a)</partNumber>
        </titleInfo>
         <identifier type="USC citation">21 U.S.C. 802</identifier>
         <identifier type="USC citation">21 U.S.C. 822</identifier>
         <identifier type="USC citation">21 U.S.C. 823(g)</identifier>
         <identifier type="USC citation">21 U.S.C. 824</identifier>
         <identifier type="USC citation">21 U.S.C. 829a(a)</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 25 Section 1616l</partNumber>
        </titleInfo>
         <identifier type="USC citation">25 U.S.C. 1616l</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 42 Section 1395cc-6(c)(3)</partNumber>
              <partNumber>Title 42 Section 1395l(bb)(3)(B)</partNumber>
              <partNumber>Title 42 Section 1395m(o)(3)(C)(ii)</partNumber>
              <partNumber>Title 42 Section 1396b(aa)(2)(C)</partNumber>
              <partNumber>Title 42 Section 290bb-36d(c)</partNumber>
              <partNumber>Title 42 Section 290dd-3</partNumber>
        </titleInfo>
         <identifier type="USC citation">42 U.S.C. 1395cc-6(c)(3)</identifier>
         <identifier type="USC citation">42 U.S.C. 1395l(bb)(3)(B)</identifier>
         <identifier type="USC citation">42 U.S.C. 1395m(o)(3)(C)(ii)</identifier>
         <identifier type="USC citation">42 U.S.C. 1396b(aa)(2)(C)</identifier>
         <identifier type="USC citation">42 U.S.C. 290bb-36d(c)</identifier>
         <identifier type="USC citation">42 U.S.C. 290dd-3</identifier>
    </relatedItem>
    <extension>
         <docClass>s</docClass>
         <accessId>BILLS-116s2074is</accessId>
         <congress>116</congress>
         <session>1</session>
         <originChamber>SENATE</originChamber>
         <currentChamber>SENATE</currentChamber>
         <billNumber>2074</billNumber>
         <billVersion reprint="false">is</billVersion>
         <fileSuffix>is</fileSuffix>
         <shortTitle type="measure">Mainstreaming Addiction Treatment Act of 2019</shortTitle>
         <officialTitle>To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.</officialTitle>
         <action date="2019-07-10">Ms. Hassan (for herself and Ms. Murkowski) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions</action>
         <congCommittee authorityId="sshr00" chamber="S" congress="116" type="S">
                                
              <name type="authority-standard">Committee on Health, Education, Labor, and Pensions</name>
                                
              <name type="authority-short">Health, Education, Labor, and Pensions</name>
                            
        </congCommittee>
         <congMember bioGuideId="H001076" chamber="S" congress="116" party="D" role="SPONSOR" state="NH">
                                
              <name type="parsed">Ms. Hassan</name>
                                
              <name type="authority-fnf">Margaret Wood Hassan</name>
                                
              <name type="authority-lnf">Hassan, Margaret Wood</name>
                                
              <name type="authority-other">Ms. Maggie Hassan</name>
                            
        </congMember>
         <congMember bioGuideId="M001153" chamber="S" congress="116" party="R" role="COSPONSOR" state="AK">
                                
              <name type="parsed">Ms. Murkowski</name>
                                
              <name type="authority-fnf">Lisa Murkowski</name>
                                
              <name type="authority-lnf">Murkowski, Lisa</name>
                            
        </congMember>
         <isPrivate>false</isPrivate>
         <isAppropriation>false</isAppropriation>
         <USCode title="21">
                                
              <section number="802"></section>
                                
              <section number="822"></section>
                                
              <section detail="(g)" number="823"></section>
                                
              <section number="824"></section>
                                
              <section detail="(a)" number="829a"></section>
                            
        </USCode>
         <USCode title="25">
                                
              <section number="1616l"></section>
                            
        </USCode>
         <USCode title="42">
                                
              <section detail="(c)(3)" number="1395cc-6"></section>
                                
              <section detail="(bb)(3)(B)" number="1395l"></section>
                                
              <section detail="(o)(3)(C)(ii)" number="1395m"></section>
                                
              <section detail="(aa)(2)(C)" number="1396b"></section>
                                
              <section detail="(c)" number="290bb-36d"></section>
                                
              <section number="290dd-3"></section>
                            
        </USCode>
    </extension>
</mods>